Good morning, Marco. Today's report is unusually close to your actual job. A JAMA paper out this week
stops measuring how long admitted patients sit in the ED and starts measuring something else — how long before an
inpatient team actually takes them over. The spread between hospitals is under four hours at some and over a day at
others, and the authors' point is that it tracks how the work is organized, not how full the building is. That's a
night-shift question. The debate follows straight from it. Also: WHO is going to try a strain-mismatched Ebola
vaccine in the DRC, and the federal vaccine advisory committee just got a new charter. Mets dropped one in Chicago.
Section A — Top Stories
Confirmed fresh, last 48 hours.
Hospital medicine · JAMA, this week
The new boarding number isn't how long they wait for a bed — it's how long before anyone upstairs owns them
A 56-emergency-department, 17-health-system study published in JAMA this week looked at 3 million adult
ED visits from June 2024 through May 2025. Of the 492,135 patients admitted to general medical care —
geriatrics, internal medicine, family medicine — 263,666 (53.6%) waited at least four hours for a bed. But the
authors measured a second, less-tracked clock: time until an inpatient team actually assumed management. On that
one, 84,936 patients (17.3%) went four hours or more with their ED care concluded and no inpatient team engaged;
22,905 (4.7%) went twelve hours; 4,497 (0.9%) went a full day. Between 54% and 55% of those delayed patients were
65 or older, and delays skewed toward Medicare coverage, higher acuity, teaching hospitals, and higher-Medicaid
hospitals. The group behind it — RESQUE-NET, founded by Alex Janke (Michigan), Adrian Haimovich (Beth Israel
Deaconess) and Ari Friedman (Penn) — makes the argument plainly: some hospitals clear the handoff in under four
hours, others take more than a day, "which suggests it comes down to how a hospital organizes the work, not just
how full it is."
(JAMA ·
CIDRAP ·
Michigan Medicine)
Why it matters to you: this is a description of your shift. The gap the paper measures — ED care
done, inpatient care not started — is exactly the window a nocturnist either closes or doesn't, and the patients
sitting in it are disproportionately the 80-year-olds on eleven medications you'd be admitting anyway. Janke's own
description of what works at Michigan is hospitalists coming down to the ED and taking over, and he's candid that
"that's not a small thing to ask of a team that already has a full service upstairs." The finding that matters for
your group isn't the national average, it's the variance: hospitals with similar occupancy land on opposite ends,
which means the lever is a written rule about who picks up the boarder at 2 a.m., not a bed.
Suggested action: worth asking at the next group meeting whether there's an explicit trigger for
when the night hospitalist assumes care of an ED boarder — a clock, a census threshold, a phone call — or whether
it's negotiated case by case. Case-by-case is what produces the 24-hour tail.
Update · DRC Ebola, Aug 20
Update: WHO is sending 70,000 Ervebo doses into a Bundibugyo outbreak — and testing whether the wrong-strain vaccine works
Yesterday's report noted that this outbreak's strain, Bundibugyo, has no licensed vaccine or therapeutic — Ervebo,
Inmazeb and Ebanga are all Zaire-strain products. Thursday the WHO released 70,000 Ervebo doses from the
International Coordinating Group stockpile at the DRC's request. Twenty thousand go into a phase 3 trial testing
whether the Zaire-strain vaccine cross-protects against Bundibugyo; the other 50,000 go to frontline health
workers. Gavi is putting $7 million behind the shipment and $6 million more toward vaccination in high-risk areas.
WHO's language is unusually careful: "It is not known whether Ervebo may be protective against the Bundibugyo virus
in humans. Early laboratory and animal data suggest it may provide some protection" — with an explicit call for
informed consent covering the limitations, inside and outside the trial. Ervebo runs about 84% effective against
Zaire. The outbreak now stands at 5,229 cases and 2,478 deaths.
(CIDRAP ·
WHO ·
Gavi)
Why it matters to you: the practical change from yesterday is small but real. If a febrile
traveler with a DRC exposure history shows up, "vaccinated against Ebola" is about to become an answer you might
actually hear — and it will mean a Zaire-strain vaccine of unknown efficacy against the circulating strain, given
under a consent form that says so. That does not change isolation, supportive care, or the phone call. It changes
how much reassurance a vaccination history buys, which is close to none.
Talking point: a clean illustration of why "is the patient vaccinated?" is an incomplete question
for anything with serotypes or strains — the same reason you ask which COVID formula and which flu season, not
just yes or no.
Policy · Federal Register, Aug 21–22
The national vaccine advisory committee's new charter directs it to consider supplements and off-label drugs as alternatives
HHS is seeking nominations for the National Vaccine Advisory Committee, the outside body that advises the
department on vaccine policy, via a Federal Register notice. The nomination call follows a charter revision last
month that instructs the committee to consider "non-immunization strategies for individuals who are unable to be
vaccinated, or who choose not to be vaccinated due to medical contraindications or strongly held personal,
conscientious or religious beliefs" — with those alternatives specified to "include healthy lifestyle and disease
prevention initiatives, off label repurposed use of existing FDA approved drugs and the use of dietary supplements
known to support healthy immune function." The revised charter, which runs to July 2028, also limits participation
by academic and industry-funded vaccine researchers in favor of more public members.
(Federal Register notice ·
CIDRAP news briefs, Aug 21 ·
NVAC charter)
Why it matters to you: not directly, and not this month — NVAC advises, it doesn't set schedules.
The downstream effect is the one that reaches your admissions: when a federal advisory charter names dietary
supplements as a category of protective alternative, the families asking you at 3 a.m. whether zinc or
high-dose vitamin D is a substitute for the shot will have a document to point at. Worth knowing the language
exists before someone quotes it to you.
Suggested action: nothing to do today. If it comes up on rounds, the accurate framing is that the
charter directs the committee to consider these options for people who aren't or won't be vaccinated —
not that any of them has been shown to substitute for vaccination.
Section B — The Debate
One live argument, both sides, no verdict.
Should hospitals be publicly graded — and eventually paid — on how long admitted patients wait in the emergency department?
Why it's live right now: CMS finalized the Emergency Care Access and Timeliness measure in the
CY2026 OPPS rule; hospital EHRs begin feeding ED flow data to the federal reporting system in January 2027,
reporting becomes mandatory in 2028, the numbers get published on Care Compare, and by 2030 they touch payment.
This week's JAMA paper put hard numbers on the variation the measure is meant to capture, which restarted
the argument about whether an ED clock is the right instrument for a hospital-wide problem.
The case for — measure it
L. Anthony Cirillo, MD, FACEP, president, American College of Emergency Physicians (ACEP statement on the final rule)
Boarding has been described, studied and deplored for twenty years without moving, and the reason is that no
one has ever been accountable for the number. Emergency physicians are managing admitted patients in hallways,
storage areas and any space that safely holds a stretcher, and hospitals can absorb that indefinitely because
it costs them nothing visible. A publicly reported measure changes the economics: a four-hour threshold drawn
from the Joint Commission's own patient-safety standard, reported on Care Compare, attaches a price to a
practice that currently has none. "You cannot fix what you refuse to measure," Cirillo argues — an imperfect
metric that forces a board-level conversation about staffed beds beats a perfect metric nobody collects.
The case against — wrong lever
Dahlia Rizk, Division of Hospital Medicine, Mount Sinai, with Joshua Lapps and Jennifer Cowart of the SHM Public Policy Committee (Health Affairs Scholar)
Boarding is a symptom, not a disease. It tracks hospital occupancy — above roughly 85%, boarding past four
hours climbs — and occupancy tracks staffed beds, which fell nationally from about 802,000 pre-pandemic to
674,000 after, against patients who are measurably sicker. The mechanisms actually holding patients are
post-acute bed scarcity, prior-authorization delays, thin weekend ancillary coverage and the Medicare
three-day rule. ED performance metrics are typically not adjusted for census or other exogenous factors, so
a public clock grades a department for the consequences of decisions made elsewhere in the building — and
rewards whoever is best at moving patients out of the counted space rather than at caring for them.
Where it might land: voluntary reporting starts January 2027, mandatory 2028, payment
consequences 2030 — and a separate
bill in the House
would push further transparency on bed availability and ED tracking.
Short shift or long one, that's everything worth knowing. Coffee, then sleep. — Your morning desk